| Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery S Lungare, K Hallam, RKS Badhan International journal of pharmaceutics 513 (1-2), 280-293, 2016 | 102 | 2016 |
| The impact of ageing on the barriers to drug delivery Y Perrie, RKS Badhan, DJ Kirby, D Lowry, AR Mohammed, D Ouyang Journal of controlled release 161 (2), 389-398, 2012 | 83 | 2012 |
| A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation B Elbakary, RKS Badhan Scientific Reports 10 (1), 3788, 2020 | 71 | 2020 |
| Development and evaluation of a novel intranasal spray for the delivery of amantadine S Lungare, J Bowen, R Badhan Journal of Pharmaceutical Sciences 105 (3), 1209-1220, 2016 | 67 | 2016 |
| Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption R Badhan, J Penny, A Galetin, JB Houston Journal of pharmaceutical sciences 98 (6), 2180-2197, 2009 | 65 | 2009 |
| In silico modelling of the interaction of flavonoids with human P-glycoprotein nucleotide-binding domain R Badhan, J Penny European journal of medicinal chemistry 41 (3), 285-295, 2006 | 60 | 2006 |
| Drug dosing during pregnancy—opportunities for physiologically based pharmacokinetic models K Abduljalil, RKS Badhan Journal of pharmacokinetics and pharmacodynamics 47 (4), 319-340, 2020 | 51 | 2020 |
| Intracellular uptake of EGCG-loaded deformable controlled release liposomes for skin cancer M Marwah, Y Perrie, RKS Badhan, D Lowry Journal of liposome research 30 (2), 136-149, 2020 | 41 | 2020 |
| Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective RKS Badhan, M Kaur, S Lungare, S Obuobi Current drug delivery 11 (4), 458-471, 2014 | 33 | 2014 |
| Development of a physiologically-based pharmacokinetic model of the rat central nervous system RKS Badhan, M Chenel, JI Penny Pharmaceutics 6 (1), 97-136, 2014 | 32 | 2014 |
| Dose optimization of chloroquine by pharmacokinetic modeling during pregnancy for the treatment of Zika virus infection O Olafuyi, RKS Badhan Journal of Pharmaceutical Sciences 108 (1), 661-673, 2019 | 31 | 2019 |
| Phytoestrogens modulate breast cancer resistance protein expression and function at the blood-cerebrospinal fluid barrier M Kaur, RKS Badhan Journal of Pharmacy and Pharmaceutical Sciences 18 (2), 132-154, 2015 | 27 | 2015 |
| Identification of putative steroid-binding sites in human ABCB1 and ABCG2 S Mares-Sámano, R Badhan, J Penny European journal of medicinal chemistry 44 (9), 3601-3611, 2009 | 27 | 2009 |
| Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling … TJ Dennison, JC Smith, RK Badhan, AR Mohammed Drug design, development and therapy, 811-826, 2017 | 26 | 2017 |
| Phytochemical mediated-modulation of the expression and transporter function of breast cancer resistance protein at the blood-brain barrier: An in-vitro study M Kaur, RKS Badhan Brain research 1654, 9-23, 2017 | 24 | 2017 |
| Design of experiments to study the impact of process parameters on droplet size and development of non-invasive imaging techniques in tablet coating TJ Dennison, J Smith, MP Hofmann, CE Bland, RK Badhan, A Al-Khattawi, ... PLoS One 11 (8), e0157267, 2016 | 23 | 2016 |
| The application of physiologically based pharmacokinetic modelling to assess the impact of antiretroviral‐mediated drug–drug interactions on piperaquine antimalarial therapy … O Olafuyi, M Coleman, RKS Badhan Biopharmaceutics & Drug Disposition 38 (8), 464-478, 2017 | 22 | 2017 |
| Development of a paediatric physiologically based pharmacokinetic model to assess the impact of drug-drug interactions in tuberculosis co-infected malaria subjects: A case … O Olafuyi, M Coleman, RKS Badhan European Journal of Pharmaceutical Sciences 106, 20-33, 2017 | 22 | 2017 |
| The optimization of methadone dosing whilst treating with rifampicin: A pharmacokinetic modeling study RKS Badhan, R Gittins, D Al Zabit Drug and alcohol dependence 200, 168-180, 2019 | 20 | 2019 |
| The impact of CYP2B6 polymorphisms on the interactions of efavirenz with lumefantrine: Implications for paediatric antimalarial therapy Z Zakaria, RKS Badhan European Journal of Pharmaceutical Sciences 119, 90-101, 2018 | 19 | 2018 |
Prof Afzal R MohammedAston Pharmacy SchoolVerified email at aston.ac.uk
